B
Bull
Bull · 25%CPHI
$2.26
情境價格
$0.904
+0.018 (+2.03%)收盤時
Loading chart…
- High
- 0.920
- Open
- 0.915
- VWAP
- 0.90
- Vol
- 124.74K
- Mkt Cap
- 4.13M
- Low
- 0.886
- Amount
- 112.69K
- EV/EBITDA, TTM
- -0.28
China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.
AI analysis of China Pharma Holdings Inc (CPHI)
sellChina Pharma Holdings Inc is not a good buy right now due to its declining performance and negative financial indicators. The stock has a current price of $0.90, which is down 25.28% year-to-date and 36.33% over the past year. Additionally, the company's gross margin is only 8.81%, indicating weak profitability. The RSI is at 33.978, suggesting the stock is oversold, but this alone does not justify a buy given the overall financial instability.
估值指標
The current forward P/E ratio for China Pharma Holdings Inc (CPHI) is 1.56, compared to its 5-year average forward P/E of 0.20.
Alphio AI Price Scenarios for CPHI
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
事件時間軸
資訊
2.007-22NewsfilterChina Pharma Holdings Prices Direct Offering of 2.5 Million Shares
7.507-22NASDAQ.COMBiotech Stocks Reach 52-Week Highs Amid Clinical Trial Progress
- 2.007-15Newsfilter
China Pharma Responds to Unusual Trading Activity
9.511-25BenzingaKeysight Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
2.007-03NASDAQ.COMWhat Is a 1‑for‑10 Reverse Stock Split?
CPHI FAQ — answered by Alphio AI
China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
China Pharma Holdings Inc is not a good buy right now due to its declining performance and negative financial indicators. The stock has a current price of $0.90, which is down 25.28% year-to-date and 36.33% over the past year. Additionally, the company's gross margin is only 8.81%, indicating weak profitability. The RSI is at 33.978, suggesting the stock is oversold, but this alone does not justify a buy given the overall financial instability.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。